{"nct_id":"NCT02295501","title":"A Prospective, Open Label, Phase 1 Safety Study of Passive Immune Therapy During Acute Ebola Virus Disease Using Transfusion of INTERCEPT Plasma Prepared From Volunteer Donors Who Have Recovered From Ebola Virus Disease","status":"TERMINATED","status_verified_date":"2021-03","start_date":"2014-12","start_date_type":null,"primary_completion_date":"2020-12","primary_completion_date_type":"ACTUAL","completion_date":"2020-12","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["CERS"]}